Publication | Closed Access

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy

Clinical Cancer StageTumor BiologyMedicineMetronomic TherapyImmunologyMyeloid-derived Suppressor CellsPathologyCancer Cell BiologyOncologyRadiation OncologyCancer ResearchMetastatic Tumor BurdenMyeloid Neoplasia